Remission from depression : a review of venlafaxine clinical and economic evidence.

Han, Donald; Wang, Edward C Y

Han, Donald; Wang, Edward C Y.

Affiliation

Han D; Wyeth Pharmaceuticals, Markham, Ontario, Canada. hando@wyeth.com

Pharmacoeconomics ; 23(6): 567-81, 2005.

Article in En | MEDLINE | ID: mdl-15960553

Subject(s)

Cyclohexanols/therapeutic use; Depression/drug therapy; Antidepressive Agents, Second-Generation/economics; Antidepressive Agents, Second-Generation/therapeutic use; Cost of Illness; Cyclohexanols/economics; Depression/economics; Humans; Remission Induction; Secondary Prevention; Venlafaxine Hydrochloride

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cyclohexanols / Depression Type of study: Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2005 Document type: Article Affiliation country: Canada Country of publication: New Zealand

Search on Google

Add to My VHL

XML

PubMed Links